SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000930413-19-001854
Filing Date
2019-06-10
Accepted
2019-06-10 17:01:23
Documents
66
Period of Report
2019-04-30

Document Format Files

Seq Description Document Type Size
1 c93732_10q.htm 10-Q 670896
2 c93732_ex31-1.htm EX-31.1 9299
3 c93732_ex31-2.htm EX-31.2 9292
4 c93732_ex32-1.htm EX-32.1 3303
5 c93732_ex32-2.htm EX-32.2 3317
  Complete submission text file 0000930413-19-001854.txt   4230441

Data Files

Seq Description Document Type Size
6 enz-20190430.xml EX-101.INS 869040
7 enz-20190430.xsd EX-101.SCH 54372
8 enz-20190430_cal.xml EX-101.CAL 42946
9 enz-20190430_def.xml EX-101.DEF 253650
10 enz-20190430_lab.xml EX-101.LAB 359665
11 enz-20190430_pre.xml EX-101.PRE 253698
Mailing Address ENZO BIOCHEM INC 60 EXECUTIVE BLVD FARMINGDALE NY 11735
Business Address 60 EXECUTIVE BLVD FARMINGDALE NY 11735 5167555500
ENZO BIOCHEM INC (Filer) CIK: 0000316253 (see all company filings)

IRS No.: 132866202 | State of Incorp.: NY | Fiscal Year End: 0731
Type: 10-Q | Act: 34 | File No.: 001-09974 | Film No.: 19889130
SIC: 8071 Services-Medical Laboratories
Assistant Director 9